Dova Pharmaceuticals Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | |
|---|---|---|---|
| Revenue | $0 | $0 | — |
| Operating income | −$13.7M | −$5.2M | −$5.2M |
| Net income | −$13.8M | −$5.4M | −$5.2M |
| Total assets | $112.2M | $96.4M | $28.7M |
| Total liabilities | $35.8M | $35.2M | $22.0M |
| Equity | $76.4M | $61.2M | $6.8M |
| EPS (diluted) | — | — | — |
| Shares out. | 25.7M | 25.7M | 17.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- —
- Net margin
- —
- Return on equity
- −18.0%
- Return on assets
- −12.3%
- Return on capital (ROCE)
- −14.8%
- Liabilities / assets
- 31.9%
- Debt / equity
- 0.47×
- Book value / share
- $2.97
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- 3.06safe
- Accruals / assets
- 35.6%high accruals
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 warning● 2 good- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Perceptive Advisors Llc10% owner | Nov 12, 2019 | J | 3.1M | — |
| Zaccardelli DavidOfficer — President & CEO | Nov 12, 2019 | D | 76,647 | — |
| Wysenski NancyDirector | Nov 12, 2019 | D | 6,274 | — |
| Stalfort SeanDirector | Nov 12, 2019 | U | 635,665 | $27.50 |
| Novak Alfred JDirector | Nov 12, 2019 | D | 6,901 | — |
| Manning Paul BDirector | Nov 12, 2019 | U | 13.0M | $27.50 |
| Laliberte KevinOfficer — Sr. VP, Product Development | Nov 12, 2019 | D | 4,761 | — |
| Jeffs RogerDirector | Nov 12, 2019 | D | 66,993 | — |
| Hoitt JasonOfficer — Chief Commercial Officer | Nov 12, 2019 | D | 9,970 | — |
| Hahn Mark WOfficer — Chief Financial Officer | Nov 12, 2019 | D | 9,024 | — |
| Goldman Steven M.Director | Nov 12, 2019 | D | 144,280 | — |
| Allen Lee F Md PhdOfficer — Chief Medical Officer | Nov 12, 2019 | D | 9,635 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureNov 12, 2019
- Entered a material agreementOct 3, 2019
- Other material eventSep 30, 2019
- Results of operationsAug 6, 2019
- Entered a material agreement · Other material eventJun 27, 2019
- Results of operationsMay 7, 2019
- Shareholder voteApr 26, 2019
- Results of operationsMar 5, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BFORM 15Nov 22, 2019
- EFFECTNov 18, 2019
- SC 13G/AAMENDMENT NO. 4 TO SCHEDULE 13GNov 18, 2019
- 4FORM 4 SUBMISSIONNov 15, 2019
- 4FORM 4 SUBMISSIONNov 12, 2019
- 4FORM 4 SUBMISSIONNov 12, 2019
- 4FORM 4 SUBMISSIONNov 12, 2019
- 4FORM 4 SUBMISSIONNov 12, 2019
- 4FORM 4 SUBMISSIONNov 12, 2019
- 4FORM 4 SUBMISSIONNov 12, 2019
- 4FORM 4 SUBMISSIONNov 12, 2019
- 4FORM 4 SUBMISSIONNov 12, 2019
- 4FORM 4 SUBMISSIONNov 12, 2019
- 4FORM 4 SUBMISSIONNov 12, 2019
- 4FORM 4 SUBMISSIONNov 12, 2019
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.